Aveanna Healthcare Holdings Inc. Common Stock AVAH

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.

• Zacks Investment Research 30 sept

  Is Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year?

  Aveanna Healthcare (AVAH) has significantly outperformed the Medical sector year-to-date, returning 56.4% compared to the sector's 2.8% average return. The company holds a Zacks Rank #2 (Buy) with consensus earnings estimates up 23.2% in the past quarter, indicating improved analyst sentiment. Charles River Laboratories (CRL) is another Medical stock outperforming with a 48.4% year-to-date return.

  

• Zacks Investment Research 31 ago

  Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna Healthcare

  The Outpatient & Home Healthcare industry is experiencing rapid growth driven by digital transformation, an aging population, and cost-effectiveness advantages. The industry has a Zacks Industry Rank #52 (top 21%) with a forward P/E of 19.1X. Four key stocks are highlighted: LifeStance Health (Rank #2) with 19.7% revenue growth, Option Care Health (Rank #2) with 1.9% revenue growth, Aveanna Healthcare (Rank #2) with 10.6% revenue growth, and DaVita (Rank #3) with 4.7% revenue growth.

  

• Zacks Investment Research 28 ago

  Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue?

  Aveanna Healthcare (AVAH) has surged 42.6% over the past month and hit a 52-week high of $14, outperforming its sector with a 69.2% year-to-date gain. The company has consistently beaten earnings estimates and carries a Zacks Rank #2 (Buy) with strong Growth and Momentum scores. While trading at a reasonable valuation relative to peers, the stock shows potential for continued gains in the coming weeks and months.

  

• GlobeNewswire Inc. 25 ago

  Aveanna to Participate in the 2026 Jefferies Healthcare Services and Technology Conference

  Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced that its management team will present at the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15, 2026 at 4:10pm CST, with 1x1 investor meetings also scheduled for that day. A webcast of the presentation will be available on the company's investor relations website.